Get a Sneek Peak at the Year Ahead in Radiopharmaceuticals
Join industry experts, Elcin Zan, MD (Cleveland Clinic) and Brian Zeglis, PhD (Hunter College), for a look-forward discussion of emerging trends and exciting developments poised to shape radiopharmaceuticals in 2025.
Recorded December 17, 2024, this educational event is of interest to investors, emerging biotech companies, and all interested in learning more about how radiopharmaceuticals are changing the way cancers are detected and treated.
REGISTER TO ACCESS REPLAY
Meet the Experts
Elcin Zan, MD
Cleveland Clinic
Elcin Zan, MD is dual board-certified radiologist specializing in neuroradiology and nuclear medicine. She currently serves as Chair of the Division of Nuclear Medicine at Cleveland Clinic. Prior to her current role, Dr. Zan worked in Molecular Imaging and Therapy at Weill Cornell Medicine, and as the Director of Nuclear Theranostics at NYU Langone Health.
Brian Zeglis, PhD
Hunter College
Dr. Brian Zeglis is Associate Professor in the Department of Chemistry at Hunter College, New York. His research focus is biochemistry, organic chemistry, inorganic chemistry and radiochemistry. Dr. Zeglis received his BA from Yale University and a PhD from the California Institute of Technology. He completed a postdoc at the Memorial Sloan Kettering Cancer Center.